Heart-Lung Machine Market Report Scope & Overview:

The Heart-Lung Machine Market size is valued at USD 2.45 Billion in 2025 and is projected to reach USD 4.66 Billion by 2035, growing at a CAGR of 6.65% during the forecast period 2025–2035.

The Heart-Lung Machine Market analysis report explores the changing trends, device advancements, and clinical practices. The growth is driven by an increase in complex cardiac procedures, need for pediatric and portable devices, addition of smart monitoring, and expansion of usage from hospitals and clinics, thereby influencing the market from 2026–2035.

Heart-Lung Machine installations surpassed 18,500 units in 2025, driven by rising cardiac surgeries, ECMO demand, and hospital adoption of advanced portable and AI-integrated systems.

Market Size and Forecast:

• Market Size in 2025: USD 2.45 Billion

• Market Size by 2035: USD 4.66 Billion

• CAGR: 6.65% from 2026 to 2035

• Base Year: 2025

• Forecast Period: 2026–2035

• Historical Data: 2022–2024

To Get more information On Heart-Lung Machine Market - Request Free Sample Report

Heart-Lung Machine Market Trends:

• Rising cardiac surgeries and complex heart procedures are driving increased adoption of heart-lung machines across hospitals and specialty centers.

• Growing use of ECMO and pediatric support systems is accelerating demand for advanced, portable, and AI-integrated devices.

• Technological innovations in monitoring, oxygenation, and pump efficiency are enhancing safety, precision, and patient outcomes.

• Expansion of cardiac care infrastructure and specialty cardiac centers is fueling higher machine installations.

• Customizable systems for adult, pediatric, and portable applications are meeting diverse clinical requirements and surgical complexities.

• Collaborations between device manufacturers, hospitals, and research institutes are fostering innovation, smarter features, and broader market reach.

U.S. Heart-Lung Machine Market Insights:

The U.S. Heart-Lung Machine Market is projected to grow from USD 0.78 Billion in 2025 to USD 1.29 Billion by 2035, at a CAGR of 5.20%. Growth is propelled by increasing cardiac surgeries, ECMO adoption, next-generation AI functional machines, rising hospital network expansion, and growing need for portable high-precision cardiac support devices.

Heart-Lung Machine Market Growth Drivers:

• Rising complex cardiac surgeries and ECMO demand driving adoption of advanced, portable, and AI-enabled heart-lung machines.

Rising complex cardiac surgeries and growing ECMO demand are key drivers of Heart-Lung Machine Market growth. Machines for heart and lung assist (e.g., portable and AI-based devices) are in demand every day in hospitals/centers needing to support high-risk procedures, patient safety, and surgical success. Market drivers, efficiency, and growth potential are driven by the expansion of cardiac care facilities (and growing use in pediatric vs. adult populations) and the technical advancements of monitoring technologies for oxygenation/pump.

Over 52% of hospitals, clinics, and pharmaceutical distributors used tamper-evident medical box sealing tapes in 2025 to ensure secure packaging and regulatory compliance.

Heart-Lung Machine Market Restraints:

• High equipment costs and stringent regulatory requirements are restricting widespread adoption of advanced heart-lung machines.

High equipment costs and stringent regulatory requirements remain key restraints for Heart-Lung Machine Market growth. These machines also include advanced and portable AI-enabled machines requiring high-precision testing, which involve a lot of investments. Small and mid-sized hospitals and specialty centers face budgetary issues that affect adoption. Regional regulations, certification, and the intricate process involved in complying with regulations are some factors that affect the penetration of advanced machines in the market, despite the growing need for cardiac surgeries, ECMO support, and advanced technology in surgeries.

Heart-Lung Machine Market Opportunities:

• Rising demand for portable, AI-integrated, and pediatric heart-lung machines offers significant market expansion opportunities.

Rising demand for portable, AI-integrated, and pediatric heart-lung machines presents significant opportunities for the Heart-Lung Machine Market. Hospitals, cardiac centers, and clinics are increasingly looking for advanced systems that will open new ways in patient safety and surgical precision and allowing complex surgical procedures. Innovative, small and smart systems allow companies to gain a competitive advantage. This presents a significant opportunity as innovation in monitoring technology, oxygen utilization and pediatric & adult systems advances the breadth of surgical, ECMO, and critical care solutions.

Over 28% of hospitals and specialty cardiac centers adopted portable or AI-integrated heart-lung machines in 2025 to enhance surgical precision and patient outcomes.

Heart-Lung Machine Market Segmentation Analysis:

• By Product / Type, Single Roller Pumps held the largest market share of 34.75% in 2025, while Portable / ECMO-compatible Systems are expected to grow at the fastest CAGR of 9.11% during 2026–2035.

• By Component, Oxygenators dominated with a 31.48% market share in 2025, whereas Monitoring Systems are projected to register the fastest CAGR of 9.45% through 2026–2035.

• By Application, Coronary Artery Bypass Grafting (CABG) accounted for the highest market share of 37.21% in 2025, while ECMO / Acute Respiratory Support is anticipated to expand at the fastest CAGR of 9.63% during the forecast period.

• By End-User, Hospitals captured the largest share of 41.87% in 2025, while Cardiac / Specialty Centers are expected to grow at the fastest CAGR of 8.97% through 2026–2035.

By Product / Type, Single Roller Pumps Dominate While Portable / ECMO-Compatible Systems Are Fastest Growing:

Single Roller Pump segment dominated the market due to being reliable and widely used for standard cardiac procedures, the single roller pump is cost-effective for both hospitals and cardiac centers. The following year, more than 6,400 units were installed, mainly to assist coronary artery bypass grafting, heart valve and routine adult cardiac operations.

Portable and ECMO-compatible systems are the fastest-growing segment, propelled through means demand for versatile, transportable, AI-based totally solutions. Installations surpassed 2,700 units in 2025, enabling emergency ECMO, and critical care and pediatric surgical procedures for hospitals and specialty centers.

By Component, Oxygenators Dominate While Monitoring Systems Are Fastest Growing:

Oxygenators segment dominated the market owing to its critical role in ensuring blood oxygenation during cardiopulmonary bypass for over 5,900 procedures in 2025. They remain the workhorses of surgical cardiac support due to their proven reliability, efficiency and compatibility with different pump systems.

Monitoring Systems are the fastest-growing segment, owing to increasing demand of AI-enabled live surgical monitoring on patient safety and outcomes. By 2025, more than 2,100 monitoring systems had been implemented in hospitals and specialty centers and provided support for advanced cardiac/ECMO cases.

By Application, Coronary Artery Bypass Grafting (CABG) Dominates While ECMO / Acute Respiratory Support Is Fastest Growing:

Coronary Artery Bypass Grafting (CABG) segment dominated the market owing to it being one of the most common heart surgeries. In CABG operations, heart-lung machines were used in above 7200 cases in year 2025, which enabled the safe cardiopulmonary support during surgical operations.

ECMO / Acute Respiratory Support is the fastest-growing segment, due to its growing adoption in ICUs, pediatric care, and critical respiratory cases. In 2025, over 2,500 machines helped perform ECMO procedures on patients, hospitals’ desperate need for advanced portable systems that can deliver life-sustaining therapies.

By End-User, Hospitals Dominate While Cardiac / Specialty Centers Are Fastest Growing:

Hospitals segment dominated the market being responsible for a majority of cardiac surgeries and maintaining large surgical units. In 2025, more than 7,800 heart-lung machines were used in hospitals to assist adult, pediatric and complex general and specialized care procedures.

Cardiac and Specialty centers are the fastest-growing segment, which is stimulated by an increased focus on dedicated cardiac care, the adoption of advanced ECMO programs in hospitals, and need for portable, AI-enabled systems. By 2025, over 2900 machines were implanted in specialty centers, in line with the growth of cardiac infrastructure.

Heart-Lung Machine Market Regional Analysis:

North America Heart-Lung Machine Market Insights:

The North America Heart-Lung Machine Market is dominant, holding a 42.36% share in 2025, centered on the capabilities of advanced cardiac care units, expanded adoption of AI-enabled and portable heart-lung machines, and established hospital and medical center infrastructure. Strong demand from cardiac surgeries, ECMO programs and pediatric care also helps drive growth. Rising investments in technological advancements, cardiac networks, and high standards of safety and regulatory compliance continue to solidify North America's position in the high-end and high-precision heart-lung machine market, which is already mature.

Get Customized Report as per Your Business Requirement - Enquiry Now

U.S. Heart-Lung Machine Market Insights:

The U.S. Heart-Lung Machine Market is fuelled by advanced cardiac care infrastructure, high surgical volumes, and stringent regulatory requirements. Increasing demand for ECMO and pediatric support, use of AI-enabled and portable machines, and hospital and specialty cardiac centers are further consolidating the position of the U.S. as the largest market for heart-lung machines in North America.

Asia-Pacific Heart-Lung Machine Market Insights:

The Asia-Pacific Heart-Lung Machine Market is the fastest-growing region, projected to expand at a CAGR of 9.02% during 2026–2035. Growth is also driven by the increasing number of cardiac surgeries, the growing infrastructure of hospital facilities, and the use of ECMO technology in countries such as China, India, Japan, and Southeast Asia. Significant investments in heart care facilities and the growing awareness of advanced heart surgery technology will continue to fuel the growth of the market in the Asia-Pacific region.

China Heart-Lung Machine Market Insights:

The China Heart-Lung Machine Market is fuelled by the increasing volumes in cardiac surgeries, rapid hospital infrastructure development, and increasing adoption of ECMO technology. Increasing investments in healthcare by the government, the need for advanced surgical equipment, and the opening of specialty cardiac centers continue to reinforce the position of China in the Asia-Pacific region for the heart-lung machines market.

Europe Heart-Lung Machine Market Insights:

The Europe Heart-Lung Machine Market is fuelled by advanced healthcare infrastructure, stringent medical device regulations, and high usage of technologically advanced cardiac support devices. The regional market is driven by rising cardiac surgeries, ECMO services, and strong hospital infrastructure in Germany, France, and the UK. Increasing investments in cardiac care technology, rising demand for portable and pediatric devices, and advancements in monitoring and oxygenation technology are further helping Europe to firmly establish its position in the heart-lung machine market during the forecast period.

Germany Heart-Lung Machine Market Insights:

Germany is a key market in the European Heart-Lung Machine landscape, backed by advanced infrastructure in cardiac care, high surgical volumes, and stringent regulations in medical devices. Growing demand for ECMO systems, a strong hospital infrastructure, and ongoing investments in cardiac surgery technology and precision monitoring systems are fueling the market growth.

Latin America Heart-Lung Machine Market Insights:

The Latin America Heart-Lung Machine Market is growing owing to the increase in the prevalence rate of cardiac diseases and the expansion of hospital infrastructure. Increasing investments in cardiac surgery units and ECMO programs are favoring growth in various regions of Brazil. Increasing usage of advanced heart-lung machines in Mexico and Argentina is favoring growth in these regions.

Middle East and Africa Heart-Lung Machine Market Insights:

The Middle East & Africa Heart-Lung Machine Market is expanding due to the development of healthcare infrastructure and the rise in investments in heart care facilities. Increasing demand for sophisticated surgical equipment and ECMO services in hospitals and clinics is fueling the market. Increasing cardiac treatment programs in Saudi Arabia, UAE, and South Africa are boosting the market.

Heart-Lung Machine Market Competitive Landscape:

Medtronic plc is a leading medical technology company that offers a wide range of cardiovascular and surgical products that are utilized by hospitals. The company has a commanding position in the heart-lung machines market due to its advanced cardiopulmonary products and expertise in cardiac surgery devices. The investments by Medtronic in research and development activities are continuously enhancing its products’ capabilities, along with innovative ECMO/perfusion technology. The wide distribution channels of Medtronic allow its heart-lung machines to be utilized by various leading hospitals due to its brand name.

• In March 2025, Medtronic plc launched the VitalFlow ECMO System, an advanced extracorporeal life-support platform designed for critical cardiac and respiratory care. The system features improved portability, integrated oxygenation technology, and simplified controls, enhancing efficiency for clinicians during complex cardiopulmonary procedures.

LivaNova PLC is a well-known medical technology company that deals with the development of cardiopulmonary and cardiac surgery products. The company has established a strong position in the heart-lung machines market by developing innovative perfusion systems, oxygenators, and extracorporeal circulation products. LivaNova PLC is a well-known developer of heart-lung machines that are widely accepted by the medical community. The company has decades of experience in developing cardiopulmonary bypass technology products. It has a strong position in the market for providing precise and efficient heart-lung machines.

• In June 2025, LivaNova PLC introduced the upgraded Essenz Perfusion System, a next-generation heart-lung platform designed to enhance cardiopulmonary bypass procedures. It includes advanced sensors, integrated patient monitoring, and intelligent control systems, improving surgical workflow, precision, and patient safety.

Getinge AB, under its MAQUET Cardiopulmonary division, is a pioneer in high-tech medical systems specifically for cardiological and intensive care applications. Getinge dominates in heart-lung machines segment with its high-end perfusion, oxygenation and ECMO products are being used in leading hospitals and specialty cardiac centers. MAQUET maintaining a commitment to innovation, patient safety and surgical productivity has gained a reputation for reliability with its products used in even the most complex cardiac patient cases. With a strong support network, thoughtful collaborations, and cutting-edge technologies behind it, Getinge is an industry leader.

• In February 2025, Getinge AB launched an enhanced MAQUET Cardiohelp ECMO platform, designed to support advanced cardiopulmonary and respiratory care. The upgraded system offers improved monitoring, compact portability, and rapid deployment capabilities for hospitals managing complex cardiac and emergency ECMO procedures.

Heart-Lung Machine Market Key Players:

Some of the Heart-Lung Machine Market Companies are: 

• Medtronic plc

• LivaNova PLC

• Getinge AB (MAQUET Cardiopulmonary)

• Terumo Cardiovascular Systems Corporation

• Braile Biomedica

• Tianjin Medical

• Edwards Lifesciences Corporation

• Nipro Corporation

• MicroPort Scientific Corporation

• Xenios AG

• Hemovent GmbH

• Eurosets S.r.l.

• Senko Medical Instrument Manufacturing Co., Ltd.

• Spectrum Medical

• Sarns (Medtronic)

• Elite LifeCare

• Advanced Perfusion Initiatives

• Abbott Laboratories

• Boston Scientific Corporation

• Fresenius Medical Care